|
"liu tw"的相关文件
显示项目 21-45 / 139 (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
| 國家衛生研究院 |
2021-11-30 |
Survival outcomes of management in metastatic gastric adenocarcinoma patients
|
Hu, HM;Tsai, HJ;Ku, HY;Lo, SS;Shan, YS;Chang, HC;Chao, Y;Chen, JS;Chen, SC;Chiang, CJ;Li, AF;Wang, HP;Wang, TE;Bai, LY;Wu, MS;Chen, LT;Liu, TW;Yang, YH |
| 國家衛生研究院 |
2021-10-19 |
Clinical outcomes of Taiwanese patients with resected oral cavity squamous cell carcinoma who underwent Reconstruction with free versus local flaps
|
Liao, CT;Wen, YW;Lee, SR;Ng, SH;Liu, TW;Tsai, ST;Tsai, MH;Lin, JC;Chien, CY;Lou, PJ;Wang, CP;Chu, PY;Leu, YS;Tsai, KY;Terng, SD;Chen, TM;Wang, CH;Chen, WC;Lee, LY;Lin, CY;Wang, HM;Fang, TJ;Huang, SF;Kang, CJ;Chang, KP;Yen, TC;Yang, LY;Lin, CH |
| 國家衛生研究院 |
2021-07-26 |
Cancer registry coding via hybrid neural symbolic systems in the cross-hospital setting
|
Dai, HJ;Yang, YH;Wang, TH;Lin, YJ;Lu, PJ;Wu, CY;Chang, YC;Lee, YQ;Zhang, YC;Hsu, YC;Wu, HH;Ke, CR;Huang, CJ;Wang, YT;Yang, SF;Hsiao, KC;Liu, KJ;Chen, LT;Chang, IS;Chao, KSC;Liu, TW |
| 臺大學術典藏 |
2021-07-07T02:40:09Z |
Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years
|
Yu, KJ; Hsu, WL; Chiang, CJ; Chen, TC; Liu, TW; PEI-JEN LOU; Diehl, S; Goldstein, AM; Chen, CJ; Wang, CP; Hildesheim, A |
| 國家衛生研究院 |
2021-05-26 |
Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis
|
Lin, MC;Leu, YS;Chiang, CJ;Ko, JY;Wang, CP;Yang, TL;Chen, TC;Chen, CN;Chen, HL;Liao, CT;Tsai, ST;Lin, JC;Chu, PY;Tsai, KY;Tsai, MH;Huang, HC;Yang, MH;Wu, YH;Terng, SD;Chien, CY;Liu, TW;Lee, WC;Lou, PJ |
| 國家衛生研究院 |
2021-05-20 |
Long-term survival effect of the interval between postoperative chemotherapy and radiotherapy in patients with completely resected pathological n2 non-small-cell lung cancer
|
Lin, SM;Ku, HY;Hsu, CY;Wang, CL;Chang, GC;Chang, CS;Liu, TW |
| 國家衛生研究院 |
2021-05 |
High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ |
| 國家衛生研究院 |
2021-05 |
A phase 2 study of liposomal irinotecan with 5-fluorouracil and leucovorin in squamous cell carcinoma of head and neck or esophagus after prior platinum-based chemotherapy or chemoradiotherapy
|
Bai, LY;Yang, MH;Chiang, NJ;Wu, SY;Lin, CY;Lien, MY;Chen, JH;Chang, MH;Hsieh, CY;Hong, RL;Kao, HF;Ye, RH;Chen, SH;Hsiao, CF;Chen, LT;Liu, TW |
| 國家衛生研究院 |
2021-02-04 |
Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer in the APHINITY trial: 6 years' follow-up
|
Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pieńkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, RD;Viale, G;Thomssen, C; the APHINITY Steering Committee and Investigators |
| 中山醫學大學 |
2021 |
Long-Term Survival Effect of the Interval between Postoperative Chemotherapy and Radiotherapy in Patients with Completely Resected Pathological N2 Non-Small-Cell Lung Cancer
|
Lin, SM; Ku, HY; Hsu, CY; Wang, CL; Chang, GC; Chang, CS; Liu, TW |
| 國家衛生研究院 |
2020-02-18 |
Impacts of intralipid on nanodrug abraxane therapy and on the innate immune system
|
Chen, YJ;Tsai, CY;Cheng, YM;Nieh, SW;Yeh, TK;Chen, CP;Wang, MH;Chou, LH;Chiu, TY;Liu, L;Ho, C;Chen, CT;Liu, TW |
| 國家衛生研究院 |
2020-02 |
Interim overall survival analysis of APHINITY (BIG 4-11): A randomized multicenter, double-blind, placebo-controlled trial comparing chemotherapy plus trastuzumab plus pertuzumab versus chemotherapy plus trastuzumab plus placebo as adjuvant therapy in pat
|
Piccart, M;Procter, M;Fumagalli, D;de Azambuja, E;Clark, E;Ewer, MS;Restuccia, E;Jerusalem, G;Dent, S;Reaby, L;Bonnefoi, H;Krop, I;Liu, TW;Pienkowski, T;Toi, M;Wilcken, N;Andersson, M;Im, YH;Tseng, LM;Lueck, HJ;Colleoni, M;Monturus, E;Sicoe, M;Guillaume, S;Bines, J;Gelber, R;Viale, G;Thomssen, C |
| 國家衛生研究院 |
2019-12-18 |
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas
|
Chen, MH;Chou, WC;Hsiao, CF;Jiang, SS;Tsai, HJ;Liu, YC;Hsu, C;Shan, YS;Hung, YP;Hsich, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
| 國家衛生研究院 |
2019-11-14 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai, HJ;Tai, JJ;Chen, LT;Wu, MS;Yeh, KH;Lin, CW;Wang, TE;Wang, HP;Yu, FJ;Liou, JM;Hsiao, CF;Cheng, TY;Yeh, HJ;Ko, CW;Chen, MJ;Lo, GH;Hsu, PI;Chang, CS;Hwang, WS;Chuang, SS;Lee, HW;Shun, CT;Chiu, CF;Wang, WM;Hsieh, CY;Liu, TW;Lin, JT;Kuo, SH;Cheng, AL |
| 國家衛生研究院 |
2019-06-21 |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, HH;Yang, HC;Hsiao, CF;Hsiung, CA;Liu, TW;Chuang, MH;Wu, HY;Hsu, YT;Tsui, CW;Chen, PJ;Cheng, AL;Hsu, C; the Taiwan Cooperative Oncology Group |
| 國家衛生研究院 |
2019-05 |
An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14)
|
Chen, MH;Chou, WC;Hsiao, CF;Liu, YC;Hsu, C;Yanshen, S;Hung, YP;Hsieh, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
| 國家衛生研究院 |
2019-01-18 |
The relationship between air pollution and lung cancer in non-smokers in Taiwan
|
Tseng, CH;Tsuang, BJ;Chiang, CJ;Ku, KC;Tseng, JS;Yang, TY;Hsu, KH;Chen, KC;Yu, SL;Lee, WC;Liu, TW;Chan, CC;Chang, GC |
| 國家衛生研究院 |
2018-09 |
Outcomes for cervical cancer patients treated with radiation in high-volume and low-volume hospitals
|
Lin, SM;Ku, HY;Chang, TC;Liu, TW;Chang, CS;Hong, JH |
| 國家衛生研究院 |
2018-07-17 |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG)
|
Hong, RL;Hsiao, CF;Ting, LL;Ko, JY;Wang, CW;Chang, JTC;Lou, PJ;Wang, HM;Tsai, MH;Lai, SC;Liu, TW |
| 國家衛生研究院 |
2018-07 |
Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis
|
Cheng, YJ;Tsai, MH;Chiang, CJ;Tsai, ST;Liu, TW;Lou, PJ;Liao, CT;Lin, JC;Chang, JT;Tsai, MH;Chu, PY;Leu, YS;Tsai, KY;Terng, SD;Chien, CY;Yang, MH;Hao, SP;Wang, CC;Tsai, MH;Chen, HHW;Kuo, C;Wu, YH |
| 國家衛生研究院 |
2018-04-07 |
The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients
|
Hung, YP;Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2018-03-15 |
Quantification of HBV core antibodies may help predict HBV reactivation in lymphoma patients with resolved HBV infection
|
Yang, HC;Tsou, HH;Pei, SN;Chang, CS;Chen, JH;Yao, M;Lin, SJ;Lin, J;Yuan, Q;Xia, N;Liu, TW;Chen, PJ;Cheng, AL;Hsu, C; Taiwan Cooperative Oncology Group |
| 國家衛生研究院 |
2018-02 |
Hospice exposure is associated with lower health care expenditures in Taiwanese cancer decedents' last year of life: A population-based retrospective cohort study
|
Hung, YN;Wen, FH;Liu, TW;Chen, JS;Tang, ST |
| 國家衛生研究院 |
2018-01-20 |
Patterns of age-specific socioeconomic inequalities in net survival for common cancers in Taiwan, a country with universal health coverage
|
Chien, LH;Tseng, TJ;Tsai, FY;Wang, JH;Hsiung, CA;Liu, TW;Chang, IS |
| 國家衛生研究院 |
2018-01 |
The association between lifestyle factors and oral potentially malignant disorders in Taiwan
|
Chen, YC;Liu, TW;Chang, JS;Yen, CY;Huang, TT;Hsiao, JR;Fan, SY;Wu, JL;Ou, CY;Yuan, SS;Liu, KJ |
显示项目 21-45 / 139 (共6页)
1 2 3 4 5 6 > >>
每页显示[10|25|50]项目
|
